Sunday, May 31, 2026
ADVT 
International

Trump issues letters, set to impose 25 pc tariffs on Japan, South Korea from Aug 1

Darpan News Desk The Canadian Press, 07 Jul, 2025 11:03 AM
  • Trump issues letters, set to impose 25 pc tariffs on Japan, South Korea from Aug 1

US President Donald Trump on Monday started sending out tariff letters to countries, saying he would impose a 25 per cent tariff on goods from Japan and South Korea from August 1. 

The US President announced the decision on his social media platform, Truth Social, where he posted copies of the letters.

The letters warned Japan and South Korea not to retaliate by increasing their own import taxes, or else the US administration would increase import taxes.

“If for any reason you decide to raise your tariffs, then, whatever the number you choose to raise them by, will be added onto the 25 per cent that we charge,” Trump said in the letters to Japanese Prime Minister Shigeru Ishiba and South Korean President Lee Jae-myung.

“Please understand that the 25 per cent number is far less than what is needed to eliminate the Trade Deficit disparity we have with your country,” Trump said in both letters, encouraging them to manufacture goods in the United States to avoid tariffs.

“There will be no tariff if South Korea or Japan or companies within your country, decide to build or manufacture product within the United States and, in fact, we will do everything possible to get approvals quickly, professionally, and routinely-In other words, in a matter of weeks,” Trump added.

Trump has threatened to send more letters out to heads of countries before the July 9 deadline, to make deals or face the threat of higher tariffs.

“These Tariffs may be modified, upward or downward, depending on our relationship with your country. You will never be disappointed with the United States of America,” Trump said in the letters sent out to Japan and South Korea.

Meanwhile, the United States' Treasury Secretary Scott Bessent said that Washington is close to reaching agreements on several trade deals as “a lot of proposals” have poured in from various countries at the last minute.

Trump has announced a number of trade deals, including with Vietnam and China. He had stated last month that the US and India “may sign an agreement that will open up India for US goods.

India’s high-level official delegation, led by chief negotiator Rajesh Agrawal, has returned from Washington after the trade talks with US officials without reaching a final agreement on the sensitive issue of trade in agricultural and dairy products that the US is pushing for.

Picture Courtesy: IANS 

MORE International ARTICLES

Attacks on older Asians stoke fear as Lunar New Year begins

Attacks on older Asians stoke fear as Lunar New Year begins
City officials also have visited Chinatowns in San Francisco and Oakland this week to address residents' safety concerns and condemn the violence.

Attacks on older Asians stoke fear as Lunar New Year begins

UN: 'Concerning news' vaccines may not work against variants

UN: 'Concerning news' vaccines may not work against variants
Tedros added that WHO expected to make a decision “in the next few days” on whether it would recommend an emergency use listing for the AstraZeneca vaccine.

UN: 'Concerning news' vaccines may not work against variants

Britain to test mixing and matching of COVID-19 vaccines

Britain to test mixing and matching of COVID-19 vaccines
The vaccines being rolled out now require two doses, and people are supposed to get two shots of the same kind, weeks apart.

Britain to test mixing and matching of COVID-19 vaccines

In U.S., Europe, hope about future health crises

In U.S., Europe, hope about future health crises
The Pew Research Center poll out today finds optimism for the future among a majority of 4,000 respondents in the U.S., the United Kingdom, France and Germany.

In U.S., Europe, hope about future health crises

Don't sell single-shot vaccine short, Fauci says

Don't sell single-shot vaccine short, Fauci says
Dr. Anthony Fauci says Johnson and Johnson's vaccine has virtues beyond an efficacy rate that lags that of its predecessors.

Don't sell single-shot vaccine short, Fauci says

A look at COVID-19 vaccines already in use, or getting close

A look at COVID-19 vaccines already in use, or getting close
AstraZeneca: Developed with Oxford University; authorized by more than 40 countries, including Britain, India, Argentina, Mexico and the European Union.

A look at COVID-19 vaccines already in use, or getting close